Banner
Facilities

Welcome to the future of translational and early clinical development.
Scientifically driven with access to multiple centres of excellence.
Customisable full service underpinned by the highest quality clinical conduct.
World-leading patient and healthy volunteer recruitment capabilities.
Delivering the best value solution for early clinical development.
At the heart of the Charité Research Organisation set-up is a state-of-the-art Phase I unit. This unit offers in-patient facilities alongside a range of function and out-patient rooms. Additional out-patient facilities are also utilised to support mass screening activities and out-patient-only studies.
The Phase I unit provides access to 70 in-patient beds, dedicated pulmonary and cardiovascular function laboratories. Additionally, CRO manufactures, stores, and dispenses investigational medicinal products (IMPs) and auxiliary medicinal products (AMPs) under a GMP-certified manufacturing license.
The unit has direct access to 24-hour emergency and intensive care services, provided by the Charité. This ensures round-the-clock access to dedicated therapeutic area specific expertise.
The location of the unit also provides easy access to all of the Charité clinics and institutes we partner with, meaning that it is easy to send subjects for diagnostic procedures such as MRI and endoscopy. Proximity to the Charité biomarker laboratories means that whole blood samples can be transferred and analysed immediately, ensuring optimum analysis for sensitive markers.
To conduct early phase oncology studies, Charité Research Organisation operates an additional Phase I unit with up to 12 beds in close collaboration with the Clinic for Hematology and Oncology of the Charité. This Phase I unit is embedded in the in-patient ward of the Oncology Department. In addition, our team has permanent access to dedicated rooms of the Oncology Department for out-patient study activities.
Get in touch with our Business Development Team to find out how Charité Research Organisation can deliver optimal value for your early clinical research projects and help you reach Proof of Concept faster.
Studienberatung
Patienten und Probanden erreichen uns unter (030) 450 539 210.
Please feel free to discuss your early clinical trials with us. Your message will be received attentively by our business development team. We come back to you with feedback from our clinicians and project management experts....
Some more text